PROVIDENTAL LABORATORIES LTD.

Follow this company
Executive Summary

Providental Laboratories Ltd. shows significant financial distress, with ongoing negative net assets and poor liquidity indicating urgent need for capital support and improved cash flow management. Immediate focused actions on cost control, financing, and strategic planning are crucial to restore financial health and sustainability. Without intervention, the company risks insolvency despite its promising niche in medical instrument manufacturing.

View Full Analysis Report →
Company Documents

DateDescription
02/03/252 March 2025 Micro company accounts made up to 2024-09-30

View Document

30/09/2430 September 2024 Annual accounts for year ending 30 Sep 2024

View Accounts

18/07/2418 July 2024 Micro company accounts made up to 2023-09-30

View Document

30/09/2330 September 2023 Annual accounts for year ending 30 Sep 2023

View Accounts

13/09/2313 September 2023 Confirmation statement made on 2023-09-13 with no updates

View Document

14/09/2214 September 2022 Incorporation

View Document

More Company Information
Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
    • Follow this company